Core Laboratories (NYSE:CLB) CEO Buys $53,900.00 in Stock

Core Laboratories Inc. (NYSE:CLB) CEO Lawrence Bruno bought 5,000 shares of the stock in a transaction dated Friday, July 31st. The stock was purchased at an average price of $10.78 per share, with a total value of $53,900.00. Following the purchase, the chief executive officer owned 262,438 shares in the company, valued at $2,829,081.64. This trade represents a 1.94% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Core Laboratories Price Performance

Shares of CLB stock opened at $11.20 on Friday. The stock has a market cap of $513.68 million, a price-to-earnings ratio of 19.99, a PEG ratio of 2.64 and a beta of 1.03. The business’s fifty day moving average is $11.76 and its 200 day moving average is $14.97. Core Laboratories Inc. has a twelve month low of $9.72 and a twelve month high of $20.36. The company has a quick ratio of 1.55, a current ratio of 2.12 and a debt-to-equity ratio of 0.41.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The business had revenue of $124.61 million during the quarter, compared to the consensus estimate of $126.26 million. During the same quarter in the prior year, the company earned $0.19 earnings per share. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Research analysts expect that Core Laboratories Inc. will post 0.53 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Monday, August 10th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, August 10th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories’s payout ratio is presently 7.14%.

Analyst Upgrades and Downgrades

CLB has been the subject of a number of analyst reports. Weiss Ratings raised shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Institutional Investors Weigh In On Core Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in the company. Summit Securities Group LLC bought a new position in Core Laboratories in the 1st quarter valued at approximately $31,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Core Laboratories in the 4th quarter worth $34,000. CWM LLC increased its holdings in shares of Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares in the last quarter. Quarry LP raised its stake in shares of Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after purchasing an additional 1,599 shares during the last quarter. Finally, Hantz Financial Services Inc. raised its stake in shares of Core Laboratories by 124.7% in the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 1,763 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.